List view / Grid view
CPhI Worldwide, organised by UBM EMEA, today announced the findings of Part II of its 2015 annual report, entitled, ‘Quality, metrics and continuous processing’, ahead of CPhI Worldwide 2015 in Madrid.
21 October 2013 | By IDT Biologika
IDT Biologika GmbH, a major developer of pharmaceutical technology and a producer of proprietary and third-party biopharmaceuticals and viral and bacterial vaccines, and Oncotec Pharma Produktion announced investments dedicated to increasing their respective production capacities.
20 July 2006 | By Howard Smith, Technical and Commercial Manager, Cambridge Biostability
Ninety per cent of the world’s medical research funding is being spent on just ten per cent of the world’s health problems, mostly those afflicting the residents of wealthy countries.
